RCS - Dr. Martens PLC - UAE distribution partnership and LATAM expansion

Dr MartensAnnouncement

Thu 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251002:nRSB6978Ba&default-theme=true

RNS Number : 6978B  Dr. Martens PLC  02 October 2025

DR. MARTENS AGREES DISTRIBUTION PARTNERSHIP FOR THE UAE, AND FURTHER EXPANSION
INTO LATIN AMERICA

 

2(nd) October 2025: Dr. Martens, the iconic British footwear brand with a
global presence, today announces a new distribution partnership agreement with
Beside Group in the UAE, representing the brand's entry into the UAE for the
first time. Additionally, the brand has partnered with Crosby in Latin
America, which opened a store in Santiago, Chile this week - its second in the
region following the opening of a store in Argentina in August.

These partnerships mark an important milestone in Dr. Martens' next phase of
growth, as part of the strategic objective of curating market-right
distribution and entering new growth markets with capital-light models.

Beside is a leading partner for international brands in the Middle East, with
significant experience in retail and wholesale, spanning several decades. The
partnership with Dr. Martens will launch and then grow the brand's presence in
the UAE, initially through wholesale, with mono-branded store openings
expected in the future.

Driven by a passion for design and quality, Crosby partners with iconic
international fashion and luxury brands, serving as their official distributor
in Latin America. The partnership with Dr. Martens will drive the brand's
reach in Mexico, Argentina, Paraguay and Chile and includes mono-branded
retail stores and wholesale. The first mono-branded Dr. Martens store opened
in Palermo, Buenos Aires, in August, to great reception. A second store, in
Santiago, opened this week, marking the brand's first store in Chile.

Ije Nwokorie, CEO of Dr. Martens, said: "These exciting partnerships are
consistent with our strategy of entering new growth markets to reach more
consumers than ever before through a capital-light approach. We see enormous
potential for Dr. Martens in the UAE and Latin America and are delighted to
have two partners who really understand both the depth and breadth of our
iconic brand."

 

Ends

 

Investors and
analysts:

Bethany Barnes, Director of Investor Relations & Corporate Communications

bethany.barnes@drmartens.com (mailto:bethany.barnes@drmartens.com)

+44782187465

 

 

Press enquiries:

Rob Greening / Ludo Baynham-Herd

drmartens@client.sodali.com (mailto:drmartens@client.sodali.com)

+44 207 250 1446

 

Notes to editors

About Dr. Martens

 

Dr. Martens is an iconic British footwear brand founded in Northamptonshire,
England. Its first silhouette, the 1460 boot - named after the date it was
produced - rolled off the production line on 1st April 1960. Originally chosen
by workers for their air-cushioned comfort and durability, "Docs" or "DM's"
were later adopted by musicians and subcultural pioneers who took them from
the street to the global stage.

Over six decades later, Dr. Martens operates in more than 60 countries and
employs around 3,700 people. The company continues to honour the brand's
heritage through its 'Made in England' footwear, manufactured at its original
Northamptonshire factory, while meeting global demand from multiple
high-quality production sites across Asia. All our products are made with an
unwavering commitment to craft, combined with innovative techniques.

Dr. Martens business spans Direct-to-Consumer (Retail and Ecommerce) and
Wholesale channels, with product segments including the brand's Original
silhouettes (the 1460 boot, 1461 shoe, 2976 Chelsea boot, and Adrian loafer),
Sandals, new product families such as Zebzag and Buzz, a Kids range, and an
expanding line of bags and accessories. Each collection embodies durability,
versatility, and individuality, while collaborations continue to push creative
boundaries and reach new wearers. Dr. Martens has transcended its roots while
staying true to its DNA - and the brand's trademark yellow welt stitching,
grooved sole edge, and scripted "With Bouncing Soles" heel loops are instantly
recognisable worldwide.

Dr. Martens plc (DOCS.L) is listed on the main market of the London Stock
Exchange and is a constituent of the FTSE 250 index.

For more information, visit www.drmartens.com or www.drmartensplc.com

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAFSDFIFEISEES